AlphaFold predicted structure
ZCCHC8 · Q6NZY4

Mean pLDDT
61.2/ 100
Low
707 residues
Confidence breakdown
- Very high(≥ 90)11%
- Confident(70–90)30%
- Low(50–70)19%
- Very low(< 50)41%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
zinc finger CCHC-type containing 8
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Pulmonary fibrosis familial
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFamilial pulmonary fibrosis
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedDDG2P
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalpulmonary fibrosis, and/or bone marrow failure, telomere-related, 5
neurodegenerative disease
dyskeratosis congenita
inherited aplastic anemia
inherited acute myeloid leukemia
glomerulonephritis
gastric adenocarcinoma
bladder transitional cell carcinoma
melanoma
diffuse large B-cell lymphoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Zinc finger CCHC domain-containing protein 8
Scaffolding subunit of the trimeric nuclear exosome targeting (NEXT) complex that is involved in the surveillance and turnover of aberrant transcripts and non-coding RNAs (PubMed:27871484). NEXT functions as an RNA exosome cofactor that directs a subset of non-coding short-lived RNAs for exosomal degradation. May be involved in pre-mRNA splicing (Probable). It is required for 3'-end maturation of telomerase RNA component (TERC), TERC 3'-end targeting to the nuclear RNA exosome, and for telomerase function (PubMed:31488579)
ZCCHC8 · Q6NZY4

Mean pLDDT
61.2/ 100
Low
707 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0